UBR2 of the N-End Rule Pathway Is Required for Chromosome Stability via Histone Ubiquitylation in Spermatocytes and Somatic Cells

• Jee Young An,

  Current address: Department of Molecular Biology, Massachusetts General Hospital, Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America

  Affiliation Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Euna Kim,

  Affiliation World Class University (WCU) Program, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Seoul National University, Seoul, Korea

  ⨯
• Adriana Zakrzewska,

  Affiliation Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Young Dong Yoo,

  Affiliation World Class University (WCU) Program, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Seoul National University, Seoul, Korea

  ⨯
• Jun Min Jang,

  Affiliation World Class University (WCU) Program, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Seoul National University, Seoul, Korea

  ⨯
• Dong Hoon Han,

  Affiliation World Class University (WCU) Program, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Seoul National University, Seoul, Korea

  ⨯
• Min Jae Lee,

  Affiliation Department of Applied Chemistry, College of Applied Sciences, Kyung Hee University, Yongin, Korea

  ⨯
• Jai Wha Seo,

  Affiliation Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Yong Jun Lee,

  Affiliation Department of Surgery and Pharmacology, School of Medicine, University of Pittsburgh, Hillman Cancer Center, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Tae-You Kim,

  Affiliations World Class University (WCU) Program, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Seoul National University, Seoul, Korea, Seoul National University Cancer Hospital and College of Medicine, Seoul, Korea

  ⨯
• Dirk G. de Rooij,

  Affiliation Reproductive Biology Laboratory, Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Bo Yeon Kim ,

  * E-mail: yok5@pitt.edu (YTK); bykim@kribb.re.kr (BYK)

  Affiliation World Class Institute, Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon, Korea

  ⨯
• Yong Tae Kwon

  * E-mail: yok5@pitt.edu (YTK); bykim@kribb.re.kr (BYK)

  Affiliations Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, World Class University (WCU) Program, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Seoul National University, Seoul, Korea

  ⨯